IDEAS home Printed from https://ideas.repec.org/a/vrs/ajbals/v11y2025i1p120-130n1010.html
   My bibliography  Save this article

Onco-Nephrology: Unraveling acute Kidney injury in Cancer and its association with Nephrotoxic Medications and Biomarkers

Author

Listed:
  • Imeraj Matilda

    (Service of Nephrology, University Hospital Center “Mother Teresa” Tirana, Albania)

  • Kreka Bledi

    (Service of Oncology, University Hospital Center “Mother Teresa” Tirana, Albania)

  • Çuedari Enkelejda

    (Service of Oncology, University Hospital Center “Mother Teresa” Tirana, Albania)

  • Idrizi Alma

    (Service of Nephrology, University Hospital Center “Mother Teresa” Tirana, Albania)

Abstract

Background The patients with malignancies are at increased risk of infection, sepsis, tumor lysis syndrome, drug-related toxicity, and other comorbidities, leading to a significantly increased risk of acute kidney injury (AKI). This prospective study analyzed the clinical data of AKI in cancer patients and explored the predictive value of Cystatin C (CysC) and neutrophil gelatinase-associated lipocalin (NGAL) in the prognosis of cancer patients with AKI. Methods Patients with malignancies, attending the Service of Oncology, University Hospital Center “Mother Teresa “Tirana, Albania from September 2024 to February 2025 were enrolled according to inclusion and exclusion criteria. Results A total of 100 patients were included. Among them, 21 cases (21 %) had AKI, and 79 cases (79%) had no AKI. Among the AKI patients, in 17 of them (81 %) the renal function recovered. Serum CysC and NGAL levels persisted elevated in patients who didn’t recover the renal function. Conclusions AKI is an important complication in cancer patients, treated with chemotherapy. Baseline NGAL and CysC levels are associated with the occurrence of AKI in cancer patients.

Suggested Citation

  • Imeraj Matilda & Kreka Bledi & Çuedari Enkelejda & Idrizi Alma, 2025. "Onco-Nephrology: Unraveling acute Kidney injury in Cancer and its association with Nephrotoxic Medications and Biomarkers," Academic Journal of Business, Administration, Law and Social Sciences, Sciendo, vol. 11(1), pages 120-130.
    • Handle: RePEc:vrs:ajbals:v:11:y:2025:i:1:p:120-130:n:1010
    DOI: 10.2478/ajbals-2025-0010
    as

    Download full text from publisher

    File URL: https://doi.org/10.2478/ajbals-2025-0010
    Download Restriction: no
    File URL: https://libkey.io/10.2478/ajbals-2025-0010?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:vrs:ajbals:v:11:y:2025:i:1:p:120-130:n:1010. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.sciendo.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.